chr4-11399717-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_005114.4(HS3ST1):āc.289A>Gā(p.Ser97Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000286 in 1,613,806 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_005114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS3ST1 | NM_005114.4 | c.289A>G | p.Ser97Gly | missense_variant | 2/2 | ENST00000002596.6 | NP_005105.1 | |
HS3ST1 | XM_011513913.4 | c.289A>G | p.Ser97Gly | missense_variant | 2/2 | XP_011512215.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS3ST1 | ENST00000002596.6 | c.289A>G | p.Ser97Gly | missense_variant | 2/2 | 1 | NM_005114.4 | ENSP00000002596 | P1 | |
HS3ST1 | ENST00000510712.1 | downstream_gene_variant | 2 | ENSP00000422629 | ||||||
HS3ST1 | ENST00000514690.5 | downstream_gene_variant | 3 | ENSP00000425673 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251180Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135860
GnomAD4 exome AF: 0.000305 AC: 446AN: 1461594Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 225AN XY: 727110
GnomAD4 genome AF: 0.000105 AC: 16AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74354
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at